Lasmiditan induces mitochondrial biogenesis in primary mouse renal peritubular endothelial cells and augments wound healing and tubular network formation
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.00116.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Austin D Thompson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, United States. Hauptthemen laut MEDLINE: Endothelial Cells, Mitochondria, Wound Healing, Organelle Biogenesis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, U.S. Department of Veterans Affairs (VA), HHS | NIH | National Institute of Environmental Health Sciences (DEHS).
Themen: Wundversorgung
Abstract (Originalsprache)
Lasmiditan, an FDA-approved HTR1F agonist, induces mitochondrial biogenesis (MB) and enhances recovery following acute kidney injury in mice. Renal microvascular endothelial cells (MV-ECs) are highly susceptible to dysfunction/rarefaction postinjury. The effect of MB on MV-EC repair/recovery is unknown. We show that lasmiditan induces MB in primary mouse renal peritubular endothelial cells and improves wound healing, endothelial tubular network formation, and barrier integrity after inflammatory-induced dysfunction, indicative of its potential for the treatment of kidney diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, United States.
- Southern Arizona VA Health Care System, Tucson, Arizona, United States.
- Southwest Environmental Health Science Center, University of Arizona, Tucson, Arizona, United States.
- College of Medicine, University of Arizona, Tucson, Arizona, United States.
ORCID-Profile: Austin D Thompson, Kai W McAlister, Natalie E Scholpa, Rick G Schnellmann
Förderung
- BLRD VA
- U.S. Department of Veterans Affairs (VA)
- HHS | NIH | National Institute of Environmental Health Sciences (DEHS)
- NIEHS NIH HHS
Zitieren
APA
Thompson, A. D., McAlister, K. W., Scholpa, N. E., Janda, J., Hortareas, J., & Schnellmann, R. G. (2025). Lasmiditan induces mitochondrial biogenesis in primary mouse renal peritubular endothelial cells and augments wound healing and tubular network formation. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00116.2025
Vancouver
Thompson AD, McAlister KW, Scholpa NE, Janda J, Hortareas J, Schnellmann RG. Lasmiditan induces mitochondrial biogenesis in primary mouse renal peritubular endothelial cells and augments wound healing and tubular network formation. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00116.2025
BibTeX
@article{Thompson2025,
author = {Thompson, Austin D and McAlister, Kai W and Scholpa, Natalie E and Janda, Jaroslav and Hortareas, John and Schnellmann, Rick G},
title = {Lasmiditan induces mitochondrial biogenesis in primary mouse renal peritubular endothelial cells and augments wound healing and tubular network formation},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.00116.2025}
}
EUVIMED